Perspectives

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Rare Diseases: Why Lexicon Matters
I often find myself cringing when I use the industry-accepted word “rare” to describe a condition or disease. As a patient advocate, I find this term to be insensitive, misleading, and at times even a little cruel.
View Aug 26, 2019
Part II: Planning the H.A.C. Event
All in, planning the hackathon took five months. In post-event debriefs among the H.A.C. MBC committee, three overarching themes for hosting a successful hackathon emerged: 
View May 22, 2019
Learning to Speak HEOR
As one formulary decision-maker told us: “Recent regulation guidance on FDAMA114 frees up pharma to be more active in sharing HEOR information, and I think that helps.”
View Dec 18, 2018